ARS Pharmaceuticals Inc. (SPRY)
ARS Pharmaceuticals Max Pain By Strike
SPRY trades at $14.53, 3.1% below the near-term max pain of $15 expiring Sep 19, 2025 (33 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($2.5-$17.5), signaling increased put positioning or downside protection. Key magnetic zone at 15 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
ARS Pharmaceuticals Max Pain By Expiry
Max pain for SPRY shows a downward trend from 17.5 to 2.5, indicating bearish sentiment or hedging activity. The 140% spread signals divergent expectations across timeframes. Levels distributed around 14.53. Strong magnetic level at 15 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 15 | 0.47 (3.23%) |
| Oct 17, 2025 | 2.5 | -12.03 (-82.79%) |
| Dec 19, 2025 | 15 | 0.47 (3.23%) |
| Jan 16, 2026 | 17.5 | 2.97 (20.44%) |
| Feb 20, 2026 | 5 | -9.53 (-65.59%) |
| Mar 20, 2026 | 15 | 0.47 (3.23%) |
| Apr 17, 2026 | 5 | -9.53 (-65.59%) |